Onco Wiki / Angabe

Parathyroid carcinoma · line 1 · None

Deterministische Ansicht der Quelle YAML Entität. Klinische Autorität bleibt mit den zitierten Quell-IDs und Rezensenten Sign-off Zustand.

Wissensdatenbank für Audit. Vorläufiger klinischer Inhalt: Dies ist kein Rezept. Ein Onkologe muss Originalquellen, Anwendbarkeit und Überprüfungsstatus überprüfen. Vollständige Regeln und Einschränkungen sind in der YAML.

Quelle YAML: Vollständige Aufzeichnung

Anmerkungen

STUB — coverage-enabling local-therapy indication for DIS-PARATHYROID-CARCINOMA. Requires endocrine-surgery / endocrine- oncology co-lead signoff before clinical publication (CHARTER §6.1 — dev-mode-exempted, safe to merge as draft content). No systemic or adjuvant drug regimen is indicated for localized, completely resected disease — surgery alone is standard of care; `recommended_regimen` is intentionally left unset (surgery-only local_therapy track, mirroring IND-MENINGIOMA-1L-RESECTION-RT). This Indication deliberately does NOT use the `phases:` / `surgery_id` mechanism (as IND-MENINGIOMA-1L-RESECTION-RT does via SUR-MENINGIOMA-RESECTION) because no Surgery entity for the en-bloc parathyroidectomy procedure has been authored yet — a follow-up authoring pass should add a Surgery/Procedure entity (proposed id SUR-PARATHYROID-EN-BLOC-RESECTION under knowledge_base/hosted/content/procedures/) and wire it via `phases` for full parity with the Meningioma pattern. The full procedure (en- bloc resection of the parathyroid tumor + ipsilateral thyroid lobe + central lymph nodes, no capsule violation) is described here in prose (rationale / do_not_do) in the interim.

Verwendet von

Algorithmen

• ALGO-PARATHYROID-CARCINOMA-1L - ALGO-PARATHYROID-CARCINOMA-1L

Erkrankung

• DIS-PARATHYROID-CARCINOMA - Nebenschilddrüsenkarzinom

Anwendungsgebiet

• IND-PARATHYROID-CARCINOMA-2L-CINACALCET - IND-PARATHYROID-CARCINOMA-2L-CINACALCET